Evolus Inc Stock Investor Sentiment
| EOLS Stock | USD 9.20 0.14 1.50% |
Slightly above 67% of Evolus' investor base is looking to short. The analysis of overall sentiment of trading Evolus Inc stock suggests that many investors are alarmed at this time. Evolus' investing sentiment can be driven by a variety of factors including economic data, Evolus' earnings reports, geopolitical events, and overall market trends.
Evolus Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Evolus can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of Evolus' Stock prices. Below is the latest headlines and news related to Evolus Inc Stock. Current markets are slightly bullish. About 58% of major world exchanges and indexes are currently up. See today's market update for more information.
There is far too much social signal, news, headlines, and media speculation about Evolus that are available to investors today. This information is accessible both publicly - through Evolus' media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Evolus-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Evolus news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Evolus relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Evolus' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Evolus alpha.
Evolus Largest EPS Surprises
Earnings surprises can significantly impact Evolus' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2025-03-04 | 2024-12-31 | 0.0223 | 0.0139 | -0.0084 | 37 | ||
2024-07-31 | 2024-06-30 | -0.05 | -0.04 | 0.01 | 20 | ||
2024-05-07 | 2024-03-31 | -0.1 | -0.09 | 0.01 | 10 | ||
2022-03-03 | 2021-12-31 | -0.19 | -0.22 | -0.03 | 15 | ||
2022-08-02 | 2022-06-30 | -0.24 | -0.28 | -0.04 | 16 | ||
2024-03-07 | 2023-12-31 | -0.07 | -0.12 | -0.05 | 71 |
There is far too much social signal, news, headlines, and media speculation about Evolus that are available to investors today. This information is accessible both publicly - through Evolus' media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Evolus-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Evolus news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Evolus relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Evolus' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Evolus alpha.
Evolus Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Evolus, Inc. Q1 2025 Earnings Call Transcript | 05/08/2025 |
2 | Disposition of 15787 shares by David Moatazedi of Evolus at 9.8661 subject to Rule 16b-3 | 05/12/2025 |
3 | Disposition of 3385 shares by Avelar Rui of Evolus at 9.8661 subject to Rule 16b-3 | 05/14/2025 |
4 | Evolus Announces Publication of U.S. Pivotal Study for Evolysse Form and Evolysse Smooth Injectable Hyaluronic Acid Gels | 05/22/2025 |
5 | Acquisition by White Albert G Iii of 20000 shares of Evolus at 9.45 subject to Rule 16b-3 | 06/09/2025 |
6 | Evolysse Recognized in 2025 Shape Skin Awards | 06/10/2025 |
7 | Mizuho Securities Reaffirms Their Buy Rating on Evolus - The Globe and Mail | 06/12/2025 |
8 | Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635 EOLS Stock News | 06/13/2025 |
9 | Disposition of 16582 shares by David Moatazedi of Evolus at 9.8935 subject to Rule 16b-3 | 06/16/2025 |
10 | Evolus, Inc. Insider David Moatazedi Sells 111,323 Shares of Stock | 06/17/2025 |
11 | When Can We Expect A Profit From Evolus, Inc. | 06/20/2025 |
12 | Evolus Expands Global Footprint with Introduction of Nuceiva in France | 07/09/2025 |
13 | What drives Evolus Inc. stock price - High-octane financial growth - Jammu Links News | 07/18/2025 |
Additional Tools for Evolus Stock Analysis
When running Evolus' price analysis, check to measure Evolus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evolus is operating at the current time. Most of Evolus' value examination focuses on studying past and present price action to predict the probability of Evolus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evolus' price. Additionally, you may evaluate how the addition of Evolus to your portfolios can decrease your overall portfolio volatility.